Status:
UNKNOWN
Tamsulosin Assisted Ureteral Access Sheath Insertion
Lead Sponsor:
Sengkang General Hospital
Conditions:
Renal Stone
Retrograde Intrarenal Surgery
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Aim is to study if 1 week of pre operative tamsulosin would enable easier insertion of ureteral access sheath in primary retrograde intrarenal surgery for renal stone disease
Eligibility Criteria
Inclusion
- renal stone undergoing retrograde intrarenal surgery
Exclusion
- not on tamsulosin or other alpha blockers regularly
- ureteral stricture
- concurrent ureteric stone
Key Trial Info
Start Date :
January 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2023
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT05197088
Start Date
January 9 2022
End Date
July 31 2023
Last Update
January 19 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.